Revvity (RVTY) RSU sell-vs-hold

Calculator · free · no signup · RVTY

Sell at vest or hold? Compare after-tax payout from selling Revvity RSUs at vest vs. holding through the LTCG cliff at 12 months.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

Your vest

pre-IPO? enter price manually

Tax inputs

Hold strategy

1 yr
20%
20%
10.0%

Best after-tax payout — at year 1 yr

$47,709

Sell + invest wins by $4,981 over Hold 1 yr.

Estimates only. Not financial advice.

This vest pushes your top federal rate from 24% to 35%. Hover the Federal value below for the bracket-by-bracket slicing.

Heads-up: under-withholding. Your employer withholds federal tax at the IRS supplemental rate (22.0% on this vest, ≈ $17,600). Your marginal federal rate on this vest is 32.7%, owing $26,171. Expect to settle the $8,571 gap at tax time.

The hidden purchase

Tax was paid at vest either way. Holding is mathematically equivalent to taking $44,509 in after-tax cash and buying $44,509 of RVTY today.

Most diversification frameworks would advise against a purchase that size in a single name; the right answer depends on your conviction in RVTY. Holding past one year converts the gain to LTCG.

Sell + invest

Best payout
Vest value (shares × price)$80,000
Federal
State
Medicare−$1,160
Additional Medicare−$720
Market gain over 1 yr at 10.0%$4,451
Cap-gain tax on diversified gain — LTCG (federal + state + NIIT)−$1,251
Net at year 1 yr$47,709

Sell every share at vest; invest the after-tax cash at the market return for 1 yr, then liquidate. Diversified — no single-stock concentration risk.

Hold 1 yr

Vest value (shares × price)$80,000
Vest tax (federal + state + FICA)
Net at year 1 yr$42,728

Sold 444 shares to cover vest tax (net-settled); kept 556 shares 1 yr to qualify for long-term capital gains.

Social Security + Medicare are payroll taxes (collectively called FICA) — they apply because you're still employed at vest.

Both columns are stated in year-1 yr dollars. The sell side compounds at the market return; the hold side compounds at your single-stock expected return after a 20% volatility drag.

Estimates only. Assumes net-settled (sell-to-cover) vesting; double-trigger and pre-IPO RSUs are out of scope. Excludes multi-state moves, AMT interactions on other equity, and 83(b) elections. Not financial advice.

You evaluated one RSU vest. The beta plans every vest of every grant across years, with concentration and AMT in the loop.

Request beta access →

Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator

About Revvity

Revvity (RVTY) is a public Life Sciences company, incorporated in Massachusetts and headquartered in Waltham, MA.

Last close: $113.75 per share (as of 2026-08-18).

Equity grants at Revvity typically include restricted stock units (RSUs).

Revvity, Inc. is a multinational company headquartered in Waltham, Massachusetts, USA, in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.

Source: Wikipedia (CC BY-SA 4.0)

PerkinElmer sold its analytical instruments business in 2023 and renamed what remained, focusing the company on life-sciences reagents, diagnostics, and newborn screening. The reagents and consumables that remain carry recurring demand tied to laboratory activity rather than to capital equipment cycles. Newborn screening is a public-health program, which makes that revenue unusually stable and policy-dependent. The name change marked a genuine change in what the company sells rather than a rebrand. Headquarters are in Waltham, Massachusetts.

Sources: sec.gov · en.wikipedia.org

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Revvity.

Revvity (RVTY) RSUs vest as ordinary income at the price on vest day. The decision is whether to sell at vest and reinvest, or hold the shares through the 12-month LTCG cliff. This calculator runs both paths through the same after-tax math so you can compare like-for-like.

Example: 500 Revvity (RVTY) RSUs vesting at $113.75 per share is $56,875 of ordinary income on vest day. After roughly 32% combined federal + state + FICA (~$18,200), the post-tax share value is ~$38,675. Holding 12 months for long-term capital-gains treatment then only matters for the price change between vest and sale; the ordinary income at vest is already locked in. The calculator runs both paths through the same after-tax math.

All Revvity tools → · Use the generic RSU Sell-vs-Hold Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →

Revvity equity questions

Should I sell or hold my Revvity RSUs at vest?
Revvity restricted stock units (RSUs) are taxed as ordinary income on their value at vest whether or not you sell. The only open decision is what to do with the shares afterward: sell at vest and reinvest, or hold past twelve months for long-term capital-gains treatment on any further gain. The calculator above runs both paths through the same after-tax math so you can compare them directly.
Does Revvity grant ISOs, NSOs, or RSUs?
Equity compensation at Revvity typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Find another companyLife Sciences Tools peers

One piece of the puzzle.

OptionsAhoy plans your Revvity equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access